# Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

> **NCT00149227** · PHASE4 · COMPLETED · sponsor: **Kyoto Prefectural University of Medicine** · enrollment: 3031 (actual)

## Conditions studied

- Hypertension
- Ischemic Heart Disease
- Congestive Heart Failure
- Stroke

## Interventions

- **DRUG:** Valsartan
- **DRUG:** Non-ARB

## Key facts

- **NCT ID:** NCT00149227
- **Lead sponsor:** Kyoto Prefectural University of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 3031 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149227, "Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00149227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*